ClinPhone and Cytel - A New Partnership Delivering Complete Solutions for Adaptive Clinical Trials 03 July 2008 Partnership combines Cytel's validated adaptive trial statistical and computational expertise with ClinPhone's suite of clinical technologies and operational know-how.
Palatin Technologies Announces Amendment Expanding AstraZeneca Obesity Collaboration 02 July 2008 AstraZeneca and Palatin amend their collaboration agreement to discover, develop and commercialize compounds that target melanocortin receptors.
Ipsogen Accelerates Its Development in Europe with the CE marking of its JAK2 Diagnostic Kits 01 July 2008 Ipsogen’s JAK2 V617F diagnostic kits are now available to all European diagnostic laboratories.
Millipore Unveils Expanded Drug Discovery Development Facility 30 June 2008 The $3.4 million expansion will enable Millipore to keep pace with the growth of its worldwide drug discovery and development business.
Lab21 Expands Cancer Gene Testing Service 27 June 2008 Lab21 has now added an epidermal growth factor receptor mutation test to its existing range.
Eden Biodesign Confirms Research Triangle Park Facility 26 June 2008 The Company expands US operation to offer a range of cell line/strain development and early process development services.
Pluristem Certified as a Good Manufacturing Practices Site for the Manufacture of PLX cells for its Clinical Trials 26 June 2008 The GMP certification has been approved for the purpose of manufacturing PLX cells which will be shipped to the EU for use in the Company’s upcoming clinical trials.
ARTEL and IonGate Join Forces to Advance Drug Discovery Research in North America 25 June 2008 IonGate will leverage ARTEL’s expertise to increase the exposure and use of its discovery systems and assay development services in North America.